All Stories

  1. Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients

    Article • Immunological Investigations, October 2019, Taylor & Francis

    hatem elalfy, tarek besheer, Prof Nasser mousa, Prof Abdel-Hady A El-Gilany

  2. Clinicopathological impact of anti-smooth muscle antibodies in patients with non-alcoholic fatty liver disease

    Article • British Journal of Biomedical Science, January 2019, Taylor & Francis

    hatem elalfy, Salwa Abo El-khair

  3. Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection

    Article • British Journal of Biomedical Science, October 2018, Taylor & Francis

    hatem elalfy, tarek besheer, Maged ELSETOUHY

  4. The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection

    Article • British Journal of Biomedical Science, August 2018, Taylor & Francis

    Maged ELSETOUHY, hatem elalfy, Moustafa Zahran, bishoy El-Aarag

  5. Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization

    Article • British Journal of Biomedical Science, August 2018, Taylor & Francis

    hatem elalfy, Ahmed Abdelkhalek

  6. Associations of human leucocyte antigen class II-DQB1 alleles with hepatitis C virus infection in Egyptian population: a multicentre family-based study

    Article • Journal of Viral Hepatitis, September 2016, Wiley

    hatem elalfy